LifeStance Health Group, Inc. LFST
14.56 USD -0.04 (-0.27%)
At closeNov 10, 2026, 4:28 PM EST
14.55 -0.01 -0.07%
After hours · Nov 10, 4:28 PM ET
14.29 Day range 14.88
6.18 52-week range 14.60
- YTD
- +106.82%
- 1 year
- +126.44%
News
zacks.com Surging Earnings Estimates Signal Upside for LifeStance Health (LFST) Stock LifeStance Health Group (LFST) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
benzinga.com LifeStance Health Group Prices Secondary Offering Of 45M Common shares At $13.12 Per Share LifeStance Health Group, Inc. ("LifeStance" or the "Company") (Nasdaq: LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health care, today announced the pricing…
globenewswire.com LifeStance Health Group Announces Pricing of Secondary Public Offering SCOTTSDALE, Ariz., Nov. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation's largest providers of virtual and in-person…
benzinga.com LifeStance Health Stockholders Launch Secondary Offering Of 45M Shares; Company Authorizes Concurrent Repurchase of 2M Shares LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ:LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health care, today announced that…
globenewswire.com LifeStance Health Group Announces Launch of Secondary Public Offering SCOTTSDALE, Ariz., Nov. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation's largest providers of virtual and in-person…
benzinga.com Canaccord Genuity Maintains Buy on LifeStance Health Gr, Raises Price Target to $16 Canaccord Genuity analyst Richard Close maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $15 to $16.
zacks.com What Makes LifeStance Health Group (LFST) a Strong Momentum Stock: Buy Now? Does LifeStance Health Group (LFST) have what it takes to be a top stock pick for momentum investors? Let's find out.
zacks.com LifeStance Health Group, Inc. (LFST) Hits Fresh High: Is There Still Room to Run? LifeStance Health (LFST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
benzinga.com Keybanc Maintains Overweight on LifeStance Health Gr, Raises Price Target to $17 Keybanc analyst Steve Dechert maintains LifeStance Health Gr (NASDAQ:LFST) with a Overweight and raises the price target from $15 to $17.
marketbeat.com What LifeStance Health Group (LFST) Said on Its Q3 Earnings Call LifeStance Health Group NASDAQ: LFST raised its full-year 2026 outlook after reporting 25% third-quarter revenue growth, driven by more patient visits and higher revenue per visit. The mental health…
benzinga.com BTIG Maintains Buy on LifeStance Health Gr, Raises Price Target to $20 BTIG analyst David Larsen maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $18 to $20.
seekingalpha.com LifeStance Health Group, Inc. (LFST) Q3 2026 Earnings Call Transcript LifeStance Health Group, Inc. (LFST) Q3 2026 Earnings Call Transcript
benzinga.com LifeStance Health Gr Q3 2026 Earnings Call Transcript LifeStance Health Gr (NASDAQ:LFST) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is…
zacks.com LifeStance Health Group (LFST) Tops Q3 Earnings and Revenue Estimates LifeStance Health Group (LFST) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to break-even earnings per share a year ago.- benzinga.com LifeStance Health Gr Sees Q4 Sales $446.000M-$466.000M vs $438.561M Est LifeStance Health Gr (NASDAQ:LFST) sees Q4 sales of $446.000 million-$466.000 million vs $438.561 million analyst estimate.
benzinga.com LifeStance Health Gr Raises FY2026 Sales Guidance from $1.685B-$1.725B to $1.741B-$1.761B vs $1.709B Est LifeStance Health Gr (NASDAQ:LFST) raises FY2026 sales outlook from $1.685 billion-$1.725 billion to $1.741 billion-$1.761 billion vs $1.709 billion estimate.
benzinga.com LifeStance Health Gr Q3 EPS $0.06 Beats $0.04 Estimate, Sales $455.900M Beat $431.816M Estimate LifeStance Health Gr (NASDAQ:LFST) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.04 by 50 percent. The company reported quarterly sales of $455.900…
globenewswire.com LifeStance Reports Strong Third Quarter 2026 Financial Results and Raises Full Year Outlook SCOTTSDALE, Ariz., Nov. 05, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial…
prnewswire.com LifeStance Patients With Treatment-Resistant Depression See Clinically Meaningful Improvement in Symptoms After Esketamine or TMS Treatment, New Data Shows LifeStance Expands Specialty Services, Increasing Access to Esketamine (Spravato) and Transcranial Magnetic Stimulation (TMS) Across the U.S. SCOTTSDALE, Ariz., Oct. 29, 2026 /PRNewswire/ --…
globenewswire.com LifeStance to Host Third Quarter 2026 Earnings Conference Call on November 5, 2026 SCOTTSDALE, Ariz., Oct. 15, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental healthcare, will issue its third quarter…
zacks.com Take the Zacks Approach to Beat the Markets: HF Sinclair, Accenture & FirstCash in Focus HF Sinclair, Accenture and FirstCash post impressive gains as Zacks research portfolios highlight standout performers amid market uncertainty and shifting investor sentiment.
benzinga.com Transcript: LifeStance Health Gr Q2 2026 Earnings Conference Call LifeStance Health Gr (NASDAQ:LFST) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings…- benzinga.com Keybanc Maintains Overweight on LifeStance Health Gr, Raises Price Target to $15 Keybanc analyst Steve Dechert maintains LifeStance Health Gr (NASDAQ:LFST) with a Overweight and raises the price target from $13 to $15.
prnewswire.com Nearly Half of Americans Say Fear of an Unwanted Viral Moment Keeps Them from Being Themselves in Public, LifeStance Survey Finds Nearly 3 in 4 Gen Zers Say Fear of an Unwanted Viral Moment Affects Their Mental Health, Self-Expression and Social Participation SCOTTSDALE, Ariz., Sept. 30, 2026 /PRNewswire/ -- A LifeStance Health…
fool.com LifeStance Health CTO Sells 42,067 Shares for $541,402 Vukasin Paunovich disposed of 42,067 shares. The transaction involved shares equal to 17% of the total stake held by the executive prior to the filing.
defenseworld.net 74,169 Shares in LifeStance Health Group, Inc. $LFST Bought by HighTower Advisors LLC HighTower Advisors LLC acquired a new position in LifeStance Health Group, Inc. (NASDAQ: LFST) during the undefined quarter, according to the company in its most recent Form 13F filing with the…
seekingalpha.com LifeStance Health Group, Inc. (LFST) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript LifeStance Health Group, Inc. (LFST) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
defenseworld.net Analyzing Mangoceuticals (NASDAQ:MGRX) and LifeStance Health Group (NASDAQ:LFST) LifeStance Health Group (NASDAQ: LFST - Get Free Report) and Mangoceuticals (NASDAQ: MGRX - Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two…
zacks.com Here's Why LifeStance Health Group (LFST) is a Great Momentum Stock to Buy Does LifeStance Health Group (LFST) have what it takes to be a top stock pick for momentum investors? Let's find out.
zacks.com 5 Low-Leverage Stocks to Buy Amid Rising Oil Prices & Inflation Woes Rising oil prices and inflation worries shift the spotlight to five low-leverage stocks, with strong earnings growth & balance sheets.
benzinga.com Barclays Maintains Overweight on LifeStance Health Gr, Raises Price Target to $15 Barclays analyst Peter Warendorf maintains LifeStance Health Gr (NASDAQ:LFST) with a Overweight and raises the price target from $13 to $15.- benzinga.com Canaccord Genuity Maintains Buy on LifeStance Health Gr, Raises Price Target to $15 Canaccord Genuity analyst Richard Close maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $13 to $15.
- benzinga.com LifeStance Prices 22.25M Share Secondary Offering At $12.35/Share; Co To Repurchase 2M Shares LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ:LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health care, today announced the pricing…
globenewswire.com LifeStance Health Group Announces Pricing of Secondary Public Offering SCOTTSDALE, Ariz., Sept. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation's largest providers of virtual and in-person…
benzinga.com BTIG Maintains Buy on LifeStance Health Gr, Raises Price Target to $18 BTIG analyst David Larsen maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $16 to $18.- benzinga.com JP Morgan Maintains Neutral on LifeStance Health Gr, Raises Price Target to $13 JP Morgan analyst Lisa Gill maintains LifeStance Health Gr (NASDAQ:LFST) with a Neutral and raises the price target from $9 to $13.
- benzinga.com BTIG Maintains Buy on LifeStance Health Gr, Raises Price Target to $16 BTIG analyst David Larsen maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $15 to $16.
- benzinga.com LifeStance Health Gr Sees Q3 Sales $420.000M-$440.000M vs $418.474M Est LifeStance Health Gr (NASDAQ:LFST) sees Q3 sales of $420.000 million-$440.000 million vs $418.474 million analyst estimate.
- benzinga.com LifeStance Health Gr Raises FY2026 Sales Guidance from $1.640B-$1.680B to $1.685B-$1.725B vs $1.665B Est LifeStance Health Gr (NASDAQ:LFST) raises FY2026 sales outlook from $1.640 billion-$1.680 billion to $1.685 billion-$1.725 billion vs $1.665 billion estimate.
- benzinga.com LifeStance Health Gr Q2 EPS $0.06 Beats $0.04 Estimate, Sales $435.354M Beat $414.577M Estimate LifeStance Health Gr (NASDAQ:LFST) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.04 by 50 percent. This is a 700 percent increase over losses of…
- benzinga.com BTIG Maintains Buy on LifeStance Health Gr, Raises Price Target to $15 BTIG analyst David Larsen maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $12 to $15.
benzinga.com Robinhood To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday Wall Street analysts change outlook on top names. See all rating changes, including upgrades and downgrades, on analyst ratings page.- benzinga.com Canaccord Genuity Maintains Buy on LifeStance Health Gr, Raises Price Target to $13 Canaccord Genuity analyst Richard Close maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $11 to $13.
- benzinga.com Barclays Maintains Overweight on LifeStance Health Gr, Raises Price Target to $13 Barclays analyst Peter Warendorf maintains LifeStance Health Gr (NASDAQ:LFST) with a Overweight and raises the price target from $9 to $13.
- benzinga.com Keybanc Maintains Overweight on LifeStance Health Gr, Raises Price Target to $13 Keybanc analyst Steve Dechert maintains LifeStance Health Gr (NASDAQ:LFST) with a Overweight and raises the price target from $11 to $13.
- benzinga.com Goldman Sachs Initiates Coverage On LifeStance Health Gr with Neutral Rating, Announces Price Target of $9 Goldman Sachs analyst Scott Fidel initiates coverage on LifeStance Health Gr (NASDAQ:LFST) with a Neutral rating and announces Price Target of $9.
- benzinga.com JP Morgan Maintains Neutral on LifeStance Health Gr, Raises Price Target to $9 JP Morgan analyst Lisa Gill maintains LifeStance Health Gr (NASDAQ:LFST) with a Neutral and raises the price target from $8 to $9.
benzinga.com Forward Air Posts Downbeat Q1 Results, Joins Upwork, HubSpot And Other Big Stocks Moving Lower In Friday's Pre-Market Session U.S. stock futures up, Dow futures gain approx. 100 pts. Forward Air Corp (FWRD) shares down 42.8% in pre-market trading. Other stocks also down.
benzinga.com Forward Air Posts Downbeat Q1 Results, Joins Upwork, HubSpot And Other Big Stocks Moving Lower In Friday's Pre-Market Session U.S. stock futures up, Dow futures gain approx. 100 pts. Forward Air Corp (FWRD) shares down 42.8% in pre-market trading. Other stocks also down.- benzinga.com BTIG Maintains Buy on LifeStance Health Gr, Raises Price Target to $12 BTIG analyst David Larsen maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $11 to $12.